In the primary site, TAM-secreted TGF-β can induce EMT and guide cancer cells to lose adhesion, becoming phenotypically more elongated and motile in a way that facilitates their entrance into the bloodstream [93,94]. The gene discussed is TGFB1; the disease is cancer.